HuGE Literature Finder
Records 1-30
|
Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Respiratory research 2021 Jan 22 (1): 3. Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow |
|
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.
The oncologist 2020 Dec . Takeda Masayuki, Takahama Takayuki, Sakai Kazuko, Shimizu Shigeki, Watanabe Satomi, Kawakami Hisato, Tanaka Kaoru, Sato Chihiro, Hayashi Hidetoshi, Nonagase Yoshikane, Yonesaka Kimio, Takegawa Naoki, Okuno Tatsuya, Yoshida Takeshi, Fumita Soichi, Suzuki Shinichiro, Haratani Koji, Saigoh Kazumasa, Ito Akihiko, Mitsudomi Tetsuya, Handa Hisashi, Fukuoka Kazuya, Nakagawa Kazuhiko, Nishio Kazu |
|
Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418).
Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, de Lima Vladmir Cordei |
|
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
|
Patients with advanced non-small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real-world data analysis.
Oncology letters 2020 Sep 20 (3): 2266-2272. Chang Nijia, Duan Jingjing, Wang Lingxiong, Dong Zhouhuan, Liu Zhefe |
|
Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non-small-cell Lung Cancer.
Clinical lung cancer 2020 Sep . Zhu Yan-Juan, Qu Xin, Zhan Dan-Dan, Chen Hui-Hui, Li Hai-Peng, Liu Li-Rong, Chen Xian, Liu Yi-Hong, Li Yong, Bai Jian-Ping, Ye Sheng, Zhang Hai- |
|
The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA.
Journal of clinical medicine 2020 Aug 9 (8): . Chang Won Jin, Sung Jae Sook, Lee Sung Yong, Kang Eun Joo, Kwon Nak-Jung, Kim Hae Mi, Shin Sang Won, Choi Jung Yoon, Choi Yoon Ji, Kim Ju Won, Park Kyong Hwa, Kim Yeul Ho |
|
Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients.
European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
|
Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution.
Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
|
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes.
Journal of cancer research and clinical oncology 2020 May . Mu Yuxin, Hao Xuezhi, Xing Puyuan, Hu Xingsheng, Wang Yan, Li Teng, Zhang Jinyao, Xu Ziyi, Li Junli |
|
Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data.
Journal of cancer research and clinical oncology 2020 Mar . Chen Huijuan, Wang Aiqin, Wang Jing, He Zeming, Mao Yanqiu, Liu Limi |
|
Impact of Somatic Mutations in Non-Small-Cell Lung Cancer: A Retrospective Study of a Chinese Cohort.
Cancer management and research 2020 12 7427-7437. Shen Hai-Bo, Li Jie, Yao Yuan-Shan, Yang Zhen-Hua, Zhou Yin-Jie, Chen Wei, Hu Tian-J |
|
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.
Oncogene 2019 Nov . Jin Ying, Bao Hua, Le Xiuning, Fan Xiaojun, Tang Ming, Shi Xun, Zhao Jun, Yan Junrong, Xu Yang, Quek Kelly, Elamin Yasir Y, Zhang Jianhua, Andrew Futreal P, Wistuba Ignacio I, Heymach John V, Lou Guangyuan, Shao Lan, He Qiong, Lin Chen, Wu Xue, Shao Yang W, Wang Xiaonan, He Jiachen, Chen Yamei, Stebbing Justin, Chen Ming, Zhang Jianjun, Yu Xinm |
|
Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Oct . Baldacci Simon, Figeac Martin, Antoine Martine, Descarpentries Clotilde, Kherrouche Zoulika, Jamme Philippe, Copin Marie-Christine, Tulasne David, Nanni Isabelle, Beau-Faller Michèle, Melaabi Samia, Levallet Guénaëlle, Quoix Elisabeth, Moro-Sibilot Denis, Friard Sylvie, Missy Pascale, Barlesi Fabrice, Cadranel Jacques, Cortot Alexis |
|
Co-occurring genetic alterations predict distant metastasis and poor efficacy of first-line EGFR-TKIs in EGFR-mutant NSCLC.
Journal of cancer research and clinical oncology 2019 Aug . Deng Li-Li, Gao Ge, Deng Hong-Bin, Wang Feng, Wang Zhi-Hui, Yang |
|
Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.
Lung cancer (Amsterdam, Netherlands) 2019 Jul 133 144-150. Aredo Jacqueline V, Padda Sukhmani K, Kunder Christian A, Han Summer S, Neal Joel W, Shrager Joseph B, Wakelee Heather |
|
Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study.
European journal of cancer (Oxford, England : 1990) 2019 Jun 116 86-97. Couraud Sébastien, Barlesi Fabrice, Fontaine-Deraluelle Clara, Debieuvre Didier, Merlio Jean-Philippe, Moreau Lionel, Beau-Faller Michèle, Veillon Rémi, Mosser Jean, Al Freijat Faraj, Bringuier Pierre-Paul, Léna Hervé, Ouafik L'Houcine, Westeel Virginie, Morel Alain, Audigier-Valette Clarisse, Missy Pascale, Langlais Alexandra, Morin Franck, Souquet Pierre-Jean, Planchard David, |
|
NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas.
Cancer medicine 2019 Jun . Tlemsani Camille, Pécuchet Nicolas, Gruber Aurelia, Laurendeau Ingrid, Danel Claire, Riquet Marc, Le Pimpec-Barthes Françoise, Fabre Elizabeth, Mansuet-Lupo Audrey, Damotte Diane, Alifano Marco, Luscan Armelle, Rousseau Benoit, Vidaud Dominique, Varin Jennifer, Parfait Beatrice, Bieche Ivan, Leroy Karen, Laurent-Puig Pierre, Terris Benoit, Blons Helene, Vidaud Michel, Pasmant Er |
|
[Genetic mutations among Chinese patients with non-small cell lung cancer and targeted therapy].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 May 36 (5): 424-428. Wang Yu, Yu Liyan, Fang Nan, Sun Bi |
|
Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.
Cancer letters 2019 Feb 442 53-67. Zhang Panpan, Kang Bin, Xie Guoyun, Li Shaolei, Gu Ying, Shen Yue, Zhao Xin, Ma Yuanyuan, Li Fuqiang, Si Jiahui, Wang Jian, Chen Jinfeng, Yang Huanming, Xu Xun, Yang Y |
|
Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome.
PloS one 2019 14 (8): e0220691. Grosse Claudia, Soltermann Alex, Rechsteiner Markus, Grosse Alexand |
|
Non-invasive detection of actionable mutations in advanced non-small-cell lung cancer using targeted sequencing of circulating tumor DNA.
Lung cancer (Amsterdam, Netherlands) 2018 Oct 124 154-159. Sim Wey Cheng, Loh Chet Hong, Toh Grace Li-Xian, Lim Chia Wei, Chopra Akhil, Chang Alex Yuan Chi, Goh Liuh Li |
|
Detection of RAS and RAS-associated alterations in primary lung adenocarcinomas. A correlation between molecular findings and tumor characteristics.
Human pathology 2018 Sep . Shaukat Irfan, Kern Jason J, Höti Naseruddin, Zhang H, Li Jason, Zheng Gang, Askin Frederic, Gabrielson Edward, Li Qing K |
|
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
Genes, chromosomes & cancer 2018 Aug . Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu |
|
Next?generation sequencing?based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her?2 and TP53 mutations in patients with non?small cell lung cancer.
Molecular medicine reports 2018 Jun . Jing Changwen, Mao Xuhua, Wang Zhuo, Sun Kejing, Ma Rong, Wu Jianzhong, Cao Haix |
|
Concomitant driver mutations in advanced EGFR -mutated non-small-cell lung cancer and their impact on erlotinib treatment.
Oncotarget 2018 May 9 (40): 26195-26208. Jakobsen Jan Nyrop, Santoni-Rugiu Eric, Grauslund Morten, Melchior Linea, Sørensen Jens Be |
|
Lung cancer in never smokers from the Princess Margaret Cancer Centre.
Oncotarget 2018 Apr 9 (32): 22559-22570. Korpanty Grzegorz J, Kamel-Reid Suzanne, Pintilie Melania, Hwang David M, Zer Alona, Liu Geoffrey, Leighl Natasha B, Feld Ronald, Siu Lillian L, Bedard Philippe L, Tsao Ming-Sound, Shepherd Frances |
|
Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.
Oncotarget 2018 Jan 9 (7): 7684-7699. Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K |
|
Racial Disparities in the Molecular Landscape of Cancer.
Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
|
Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer.
Cancer genomics & proteomics 0 17 (5): 597-603. Chevallier Mathieu, Tsantoulis Petros, Addeo Alfredo, Friedlaender Al |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: